PolyMedica boss blasts whispering campaign
This article was originally published in Clinica
Executive Summary
Stung by a week in which his company saw its share price plunge from more than $26 to just above $15 and its reputation challenged, PolyMedica's chairman and CEO Steven Lee has responded by saying that the company has been victim of a "barrage of anonymous and unsubstantiated rumours".